A Combined In Vivo HSC Transduction/Selection Approach Results in Efficient and Stable Gene Expression in Peripheral Blood Cells in Mice-Reference-Cited by-同舟云学术

A Combined In Vivo HSC Transduction/Selection Approach Results in Efficient and Stable Gene Expression in Peripheral Blood Cells in Mice

Published:2018-03 Issue: Volume:8 Page:52-64
ISSN:2329-0501
Container-title:Molecular Therapy - Methods & Clinical Development
language:en
Short-container-title:Molecular Therapy - Methods & Clinical Development

Author:

Wang Hongjie,Richter Maximilian,Psatha Nikoletta,Li Chang,Kim Jiho,Liu Jing,Ehrhardt Anja,Nilsson Susan K.,Cao Benjamin,Palmer Donna,Ng Philip,Izsvák Zsuzsanna,Haworth Kevin G.,Kiem Hans-Peter,Papayannopoulou Thalia,Lieber André

Funder

NIH

“Wings of Karen” Foundation

Marsha Rivkin Foundation

Fred Hutchinson Cancer Research Center

Chinese Scholarship Council

Publisher

Elsevier BV

Subject

Genetics,Molecular Biology,Molecular Medicine

Reference28 articles.

1. In vivo transduction of primitive mobilized hematopoietic stem cells after intravenous injection of integrating adenovirus vectors;Richter;Blood,2016

2. Measles virus spread and pathogenesis in genetically modified mice;Mrkic;J. Virol.,1998

3. Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates;Mátés;Nat. Genet.,2009

4. Concise review: sowing the seeds of a fruitful harvest: hematopoietic stem cell mobilization;Hoggatt;Stem Cells,2013

5. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist;Broxmeyer;J. Exp. Med.,2005

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Auto-expansion of in vivo HDAd-transduced hematopoietic stem cells by constitutive expression of tHMGA2;Molecular Therapy - Methods & Clinical Development;2024-09

2. CRISPR/Cas9 genome editing of CCR5 combined with C46 HIV-1 fusion inhibitor for cellular resistant to R5 and X4 tropic HIV-1;Scientific Reports;2024-05-13

3. In vivo selection of anti-HIV-1 gene-modified human hematopoietic stem/progenitor cells to enhance engraftment and HIV-1 inhibition;Molecular Therapy;2023-12

4. Swapping the serotype: A novel helper-dependent adenoviral vector platform for in vivo HSC gene therapy;Molecular Therapy - Methods & Clinical Development;2023-09

5. HDAd6/35++ - A new helper-dependent adenovirus vector platform for in vivo transduction of hematopoietic stem cells;Molecular Therapy - Methods & Clinical Development;2023-06